Antagonists of prostaglandin D2 receptors
US8497381B2 · kind B2 · utility
5Cited by
10References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2009 |
| Grant date | Jul 30, 2013 |
| Priority date | — |
| Expiry date | May 18, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D263/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.